Author

Alexander B. Postnikov

Observed names: A B Postnikov, A POSTNIKOV, A. B. Postnikov, A. Postnikov, A.B. Postnikov, Alexander B Postnikov, Alexander Postnikov, Alexander B. Postnikov, А. Б. Постников, А.Б. Постников, Постников, А. Б.

Institution: HyTest (Finland)

Observed institutions: Russian Academy of Sciences, Lomonosov Moscow State University, Semenov Institute of Chemical Physics, A N Bach Institute of Biochemistry, Ministry of Health of the Russian Federation, HyTest (Finland), Institute of Biomedical Chemistry

ORCID: 0000-0002-7974-8665

Observed ORCID: 0000-0002-7974-8665

OpenAlex ID: A5111498839

Processing of Pro–B-Type Natriuretic Peptide: Furin and Corin as Candidate Convertases2

2010 · Alexander G Semenov, Natalia N Tamm, et al. · Clinical Chemistry · 171

PDF

Processing of Pro–Brain Natriuretic Peptide Is Suppressed by O-Glycosylation in the Region Close to the Cleavage Site

2009 · Alexander G Semenov, Alexander B Postnikov, et al. · Clinical Chemistry · 155

Immunodetection of Glycosylated NT-proBNP Circulating in Human Blood

2008 · Karina R Seferian, Natalia N Tamm, et al. · Clinical Chemistry · 115

N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia

2012 · A.B. Postnikov, T.I. Smolyanova, et al. · Clinical Biochemistry · 43

Novel Immunoassay for Quantification of Brain Natriuretic Peptide and Its Precursor in Human Blood

2008 · Natalia N Tamm, Karina R Seferian, et al. · Clinical Chemistry · 41

Human Pro–B-Type Natriuretic Peptide Is Processed in the Circulation in a Rat Model

2011 · Alexander G Semenov, Karina R Seferian, et al. · Clinical Chemistry · 36

CT-IGFBP-4 as a Novel Prognostic Biomarker in Acute Heart Failure

2020 · Alexey A. Konev, Alexey V. Kharitonov, et al. · ESC Heart Failure · 27

PDF

Characterization of endogenously circulating IGFBP-4 fragments—Novel biomarkers for cardiac risk assessment

2015 · Alexey A. Konev, Tatyana I. Smolyanova, et al. · Clinical Biochemistry · 23

IGFBP-4 Proteolysis by PAPP-A in a Primary Culture of Rat Neonatal Cardiomyocytes under Normal and Hypertrophic Conditions

2021 · Daria V. Serebryanaya, Daria A. Adasheva, et al. · Biochemistry (Moscow) · 14

Clinical differences between total PAPP-A and measurements specific for the products of free PAPP-A activity in patients with stable cardiovascular disease

2013 · Olaf Schulz, Alexander B. Postnikov, et al. · Clinical Biochemistry · 14

2010 · Olga V. Shcherbakova, Daria V. Serebryanaya, et al. · Biochemical Journal · 14

PDF

Detection of Neprilysin-Derived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure

2019 · Evgeniya E Feygina, Marina M Artemieva, et al. · Clinical Chemistry · 12

PDF

Antitumor antibiotic streptonigrin and its derivatives as inhibitors of nitric oxide-dependent activation of soluble guanylyl cyclase

2003 · Irina S. Severina, Natalya V. Pyatakova, et al. · European Journal of Pharmacology · 12

Glycosylated and non-glycosylated NT-IGFBP-4 in circulation of acute coronary syndrome patients

2018 · Alexey A. Konev, Daria V. Serebryanaya, et al. · Clinical Biochemistry · 10

PDF

High throughput testing of drug library substances and monoclonal antibodies for capacity to reduce formation of cystatin C dimers to identify candidates for treatment of hereditary cystatin C amyloid angiopathy

2011 · Gustav Östner, Veronica Lindström, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 10

PDF

PAPP-A-Specific IGFBP-4 Proteolysis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

2023 · Daria A. Adasheva, Olga S. Lebedeva, et al. · International Journal of Molecular Sciences · 9

PDF

Dry-Reagent Double-Monoclonal Assay for Cystatin C

2010 · Noora Ristiniemi, Qiu-Ping Qin, et al. · Clinical Chemistry · 8

A new system of nitric oxide donor prolonged delivery on basis of controlled-release polymer, polyhydroxybutyrate

2005 · A BONARTSEV, A POSTNIKOV, et al. · American Journal of Hypertension · 8

Cytokine production in an ex vivo model of SARS-CoV-2 lung infection

2024 · Daria A. Vorobyeva, Daria M. Potashnikova, et al. · Frontiers in Immunology · 6

PDF

Specific cleavage of IGFBP-4 by papp-a in nervous tissue

2024 · German A. Dya, Olga S. Lebedeva, et al. · Biochemical and Biophysical Research Communications · 6

[Involvement of tetrahydrobiopterin in local change of endothelium-dependent vasorelaxation in pulmonary hypertension].

2003 · M P Davydova, A B Postnikov, et al. · PubMed · 6

Endothelin-Converting Enzyme Inhibition in the Rat Model of Acute Heart Failure: Heart Function and Neurohormonal Activation

2009 · Victoriya A. Rufanova, Vladimir F. Pozdnev, et al. · Experimental Biology and Medicine · 3

Effect of Chronic Administration of Aminoguanidine on Vascular Reactivity of the Greater Circulation in Rats with Monocrotaline-induced Pulmonary Hypertension

2005 · A. P. Bonartsev, K. B. D’yakonov, et al. · Biology Bulletin · 2

PAPP-A-Mediated Proteolytic Cleavage of IGFBP-4 and Age-Related Changes in the Primary Culture of Rat Astrocytes

2025 · D. A. Gushchevarov, I. M. Ermakov, et al. · Neurochemical Journal · 1

[Dynamic of myocarditis development in rats after injection of cardiac myosine combined with IFA].

2012 · M P Morozova, S A Gavrilova, et al. · PubMed · 1

Works count: 54

Citation count: 754

H-index: 12

I10-index: 15